Related Experiment Video
Updated: Aug 24, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study
Won Sup Oh1, Ji Yoeun Suh, Jae-Hoon Song
1Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Korea.
Abstract:
Seventeen clinical isolates of Streptococcus pneumoniae showing reduced susceptibility to ciprofloxacin (MIC >/= 4 micro g/ml) collected from eight different Asian countries were analyzed by antimicrobial susceptibility, serotyping, pulsed-field gel electrophoresis (PFGE), and DNA sequencing of the quinolone resistance-determining regions (QRDRs) in gyrA, gyrB, parC, and parE. All isolates but one showed more than one amino acid alteration in QRDRs of four responsible genes. Ile460 --> Val in parE was the most common mutation. Data suggest that Lys137 --> Asn in parC may be a primary step in the development of high-level and multiple FQ resistance. An additional mutation of Ser81 --> Phe in gyrA resulted in high-level resistance to ciprofloxacin, levofloxacin, and gatifloxacin, whereas Ser79 --> Phe in parC may exert an important role in the development of moxifloxacin resistance. Two novel amino acid changes in gyrB, Ala390 --> Val and Asn423 --> Thr, were found. Data from PFGE suggest an introduction and local spread of multiple resistant Spain(23F)-1 clone in Hong Kong, but isolates from other Asian countries were not related to this clone.
Insights
Reduced susceptibility to ciprofloxacin in Streptococcus pneumoniae is linked to multiple genetic mutations. Specific alterations in gyrA, gyrB, parC, and parE genes contribute to fluoroquinolone resistance in these bacterial isolates.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Background:
- Streptococcus pneumoniae is a leading cause of bacterial pneumonia and meningitis.
- Fluoroquinolone antibiotics are crucial for treating pneumococcal infections.
- Emergence of fluoroquinolone resistance in S. pneumoniae poses a significant public health threat.
Purpose of the Study:
- To investigate the genetic mechanisms underlying reduced susceptibility to ciprofloxacin in clinical isolates of Streptococcus pneumoniae from Asia.
- To identify specific mutations in quinolone resistance-determining regions (QRDRs) associated with fluoroquinolone resistance.
Main Methods:
- Antimicrobial susceptibility testing was performed on 17 clinical isolates.
- Serotyping and pulsed-field gel electrophoresis (PFGE) were used for molecular characterization.
- DNA sequencing of gyrA, gyrB, parC, and parE genes was conducted to identify mutations in QRDRs.
Main Results:
- All but one isolate exhibited multiple amino acid alterations in the QRDRs of gyrA, gyrB, parC, and parE.
- Ile460 --> Val in parE was the most frequent mutation.
- Specific mutations, such as Lys137 --> Asn in parC and Ser81 --> Phe in gyrA, were associated with high-level fluoroquinolone resistance.
- Two novel mutations in gyrB (Ala390 --> Val and Asn423 --> Thr) were identified.
- PFGE suggested the local spread of a multidrug-resistant Spain(23F)-1 clone in Hong Kong.
Conclusions:
- Multiple genetic mutations in QRDRs are responsible for reduced ciprofloxacin susceptibility in S. pneumoniae.
- Specific mutations in parC and gyrA play key roles in developing high-level and multidrug resistance.
- The Spain(23F)-1 clone may be spreading in Hong Kong, necessitating further surveillance.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial DNA Synthesis
Clinical Significance of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance
Atypical Pneumonia